Document:

Retention Agreement - Robert Mittendorff

 Exhibit 10.58 

RETENTION AGREEMENT 

This Retention Agreement (the “Agreement”) is entered into as of January 11, 2010 (the “Effective
Date”), by and between Dr. Robert Mittendorff (the “Executive”) and Hansen Medical, Inc. (the “Corporation”). 

AGREEMENT 
 In
consideration of the promises and mutual covenants set forth herein, the parties hereby agree as follows: 
 1.
Definitions. As used in this Agreement, unless the context requires a different meaning, the following terms shall have the meanings set forth herein: 

(a) “Board” shall mean the Board of Directors of the Corporation. 

(b) “Cause” shall mean any of the following: (i) an intentional unauthorized use or disclosure of the
Corporation’s confidential information or trade secrets, which use or disclosure causes material harm to the Corporation, (ii) a material breach of any agreement between Executive and the Corporation, (iii) a material failure to
comply with the Corporation’s written policies or rules, (iv) conviction of: or plea of “guilty” or “no contest” to, a felony under the laws of the United States or any state thereof, (v) gross negligence or
willful misconduct or (vi) a continued failure to perform assigned duties after receiving written notification of such failure from the Board. Executive shall not be deemed to have been terminated for Cause unless and until there shall have
been delivered to Executive a Notice of Termination and copy of a resolution duly adopted by the affirmative vote of not less than three-quarters of those members of the Board who are not then employees of the Corporation at a meeting of the Board
called and held for the purpose (after reasonable notice to Executive and an opportunity for Executive, together with Executive’s counsel, to be heard before the Board), finding that, in the good faith opinion of the Board, Executive was guilty
of the conduct set forth in the first sentence of this Section 1(b) and specifying the particulars thereof in detail. 

(c) “Change in Control” means the occurrence of any of the following events: 

(i) a transaction or series of transactions (other than an offering of the Corporation’s Common Stock to the general public through
a registration statement filed with the Securities and Exchange Commission) whereby any “person” or related “group” of “persons”, as such terms are used in Sections 13(d) and 14(d)(2) of the Exchange Act (other than the
Corporation, any of its subsidiaries, an employee benefit plan maintained by the Corporation or any of its subsidiaries or a “person” that, prior to such transaction, directly or indirectly controls, is controlled by, or is under common
control with, the Corporation) directly or indirectly acquires beneficial ownership (within the meaning of Rule l3d-3 under the Exchange Act) of securities of the Corporation possessing more than 50% of the total combined voting power of the
Corporation’s securities outstanding immediately after such acquisition; or 
  

 1 

 (ii) During any period of two consecutive years, individuals who, at the beginning of such
period, constitute the Board together with any new director(s) (other than a director designated by a person who shall have entered into an agreement with the Corporation to effect a transaction described in Section I(c)(i) or Section I(c)(iii))
whose election by the Board or nomination for election by the Corporation’s stockholders was approved by a vote of at least two-thirds of the directors then still in office who either were directors at the beginning of the two-year period or
whose election or nomination for election was previously so approved, cease for any reason to constitute a majority thereof; or 

(iii) The consummation by the Corporation (whether directly involving the Corporation or indirectly involving the Corporation through
one or more intermediaries) of (x) a merger, consolidation, reorganization, or business combination or (y) a sale or other disposition of all or substantially all of the Corporation’s assets in any single transaction or series of
related transactions, in each case, other than a transaction: 
 (A) Which results in the Corporation’s voting securities
outstanding immediately before the transaction continuing to represent (either by remaining outstanding or by being converted into voting securities of the Corporation or the person that, as a result of the transaction, controls, directly or
indirectly, the Corporation or owns, directly or indirectly, all or substantially all of the Corporation’s assets or otherwise succeeds to the business of the Corporation (the Corporation or such person, the “Successor Entity”))
directly or indirectly, at least a majority of the combined voting power of the Successor Entity’s outstanding voting securities immediately after the transaction, and 

(B) After which no person or group beneficially owns voting securities representing 50% or more of the combined voting power of the
Successor Entity; provided, however, that no person or group shall be treated for purposes of this Section 1(c)(iii)(B) as beneficially owning 50% or more of combined voting power of the Successor Entity solely as a result of the voting power
held in the Corporation prior to the consummation of the transaction. 
 (d) “COBRA” shall mean the
Consolidated Omnibus Budget Reconciliation Act of 1985, as amended. 
 (e) “COBRA Coverage” shall mean the
coverage under the Corporation’s medical, dental and/or vision benefit plans that Executive and/or Executive’s eligible dependents participates following a termination of employment pursuant to COBRA. 

(f) “Code” shall mean the Internal Revenue Code of I 986, as amended. 

(g) “Covered Termination” shall mean (i) an Involuntary Termination Without Cause or (ii) a voluntary
termination of employment by Executive for Good Reason, provided that in either case, the termination constitutes a Separation from Service. 

(h) “Date of Termination” shall mean (i) if Executive’s employment is terminated due to Executive’s
death, the date of Executive’s death; (ii) if Executive’s employment is terminated for Disability, thirty (30) days after Notice of Termination is given (provided that Executive shall not have returned to the full time
performance of Executive’s duties during such thirty (30) day period), and (iii) if Executive’s employment is terminated for any reason other than death or Disability, the date specified in the Notice of Termination. 

 

 2 

 (i) “Disability” shall mean Executive’s absence from the full-time
performance of Executive’s duties with the Corporation for six (6) consecutive months by reason of Executive’s physical or mental illness. 

(j) “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended. 

(k) “Good Reason” shall mean Executive’s resignation due to any of the following events which occurs without
Executive’s written consent, provided that the requirements regarding advance notice and an opportunity to cure set forth below are satisfied: (i) a material diminution of Executive’s compensation, including but not limited to, base
salary, other than in connection with an across-the-board reduction in the compensation of the Company’s senior management that does not disproportionately affect Executive, (ii) a material diminution of Executive’s authority, duties
or responsibilities, or (iii) a material change in the geographic location at which Executive must perform services for the Corporation (each of (i), (ii) and (iii), a “Good Reason Condition”). In order for Executive to
resign for Good Reason, Executive must provide written notice to the Corporation of the existence of the Good Reason Condition within 90 days of the initial existence of such Good Reason Condition. Upon receipt of such notice of the Good Reason
Condition, the Corporation will be provided with a period of 30 days during which it may remedy the Good Reason Condition and not be required to provide for the payments and benefits described herein as a result of such proposed resignation due to
the Good Reason Condition specified in the Notice of Termination. If the Good Reason Condition is not remedied within the period specified in the preceding sentence, Executive may resign based on the Good Reason Condition specified in the Notice of
Termination effective no later than 180 days following the initial existence of such Good Reason Condition. 
 (l)
“Involuntary Termination Without Cause” shall mean termination of Executive’s employment by the Corporation other than for Cause. The termination of Executive’s employment as a result of Executive’s death or inability
to perform the essential functions of his job due to Disability will not be deemed to be an Involuntary Termination Without Cause. 

(m) “Notice of Termination” shall mean a notice from Executive or the Corporation to the other party regarding the
intent to terminate Executive’s employment. To the extent applicable, the Notice of Termination shall indicate the specific termination provision in this Agreement (if any) relied upon and shall set forth in reasonable detail the facts and
circumstances claimed to provide a basis for termination of Executive’s employment under the provision so indicated. 
 (n)
“Release” shall mean a release by Executive of all claims arising out of Executive’s employment with the Corporation or the termination thereof, in a form reasonably acceptable to the Corporation. 

(o) “Separation from Service” means Executive’s termination of employment or service which constitutes a
“separation from service” within the meaning of Treasury Regulation Section 1.409A-1(h). 
  

 3 

 2. Notice. 

(a) Notice of Termination. Any termination of Executive’s employment by the Corporation or by Executive (other than
termination due to Executive’s death, which shall terminate Executive’s employment automatically) shall be communicated by a written Notice of Termination to the other party hereto in accordance with Section 2(b) and shall set forth
the Date of Termination, which shall not be earlier than the date on which the Notice of Termination is provided. 
 (b)
Manner of Notice. For purposes of this Agreement, a Notice of Termination, as well as other notices and communications provided for in this Agreement, shall be in writing and shall be deemed to have been duly given when delivered or mailed by
United States certified or registered mail, return receipt requested, postage prepaid, addressed to the Corporation at its principal office or to Executive at the address in the Corporation’s payroll records, provided that all notices to the
Corporation shall be directed to the attention of its Secretary, or to such other address as either party may have furnished to the other in writing in accordance herewith, except that notice of change of address shall be effective only upon
receipt. 
 3. Compensation upon Certain Terminations. 

(a) Termination for Any Reason. Upon Executive’s termination of employment with the Corporation for any reason, Executive
shall be paid all amounts earned or accrued but unpaid as of the Executive’s termination of employment, including (i) base salary, (ii) reimbursement for reasonable and necessary expenses incurred by the Executive on behalf of the
Corporation during the period ending on the date of termination, (iii) pay for unused vacation time, (iv) any bonuses and incentive compensation earned through the date of termination, and (v) reimbursement for any unused amounts
deposited in the Corporation’s ESPP. 
 (b) Covered Termination Prior to a Change in Control or More Than Twelve Months
After a Change in Control. If Executive’s employment with the Corporation is terminated due to a Covered Termination which occurs prior to a Change in Control or more than twelve (12) months following a Change in Control, and Executive
executes and does not revoke a Release as described in Section 3(d) below, then Executive shall be entitled to the following severance benefits: 

(i) Severance Payment. Executive shall be entitled to severance payments equal to six (6) months worth of the
Executive’s then-current annual base salary (commencing as of the Date of Termination), which payments shall be paid in accordance with the Corporation’s normal payroll procedures, except that any payments that would otherwise have been
made before the first normal payroll payment date falling on or after the date on which the Release becomes irrevocable (the “First Payment Date”) shall be made on the First Payment Date. 

(ii) Continued Benefits. For the period beginning on the Date of Termination and extending through the earlier of either
(A) six (6) months from the Date of Termination, or (B) the first day of Executive’s eligibility to participate in a comparable group health plan maintained by a subsequent employer, the Corporation shall pay COBRA Coverage for
Executive and Executive’s dependents. 
  

 4 

 (c) Covered Termination Within Twelve Months After a Change in Control. If
Executive’s employment with the Corporation is terminated due to a Covered Termination which occurs within twelve (12) months following a Change in Control, and Executive executes and does not revoke a Release as described in
Section 3(d) below, then Executive shall be entitled to the following severance benefits: 
 (i) Acceleration of Equity
Awards. The vested portion of each option to purchase the Corporation’s capital stock, restricted share award or other equity award with regard to the Corporations’ capital stock that Executive then holds shall be determined by adding
an additional six (6) months to the Executive’s actual period of service with the Corporation. 
 (ii) Severance
Payment. Executive shall be entitled to a lump-sum severance payment equal to six (6) months’ worth of the Executive’s then-current annual base salary compensation (measured as of the Date of Termination), which shall be paid on
the First Payment Date. 
 (iii) Continued Benefits. For the period beginning on the Date of Termination and extending
through the earlier of either (A) six (6) months from the Date of Termination, or (B) the first day of Executive’s eligibility to participate in a comparable group health plan maintained by a subsequent employer, the Corporation
shall pay COBRA Coverage for Executive and Executive’s dependents. 
 (d) Release. As a condition to
Executive’s receipt of any benefits described in this Section 3 (other than in Section 3(a)), Executive shall be required to execute a Release within fifty (50) days following the Date of Termination and not revoke such Release
within any period permitted under applicable law. Such Release shall specifically relate to all of Executive’s rights and claims in existence at the time of such execution but shall exclude any continuing obligations the Corporation may have to
Executive following the date of termination under this Agreement or any other agreement providing for obligations to survive Executive’s termination of employment. 

4. Section 409A. Notwithstanding any provision to the contrary in this Agreement, if Executive is deemed by the Corporation
at the time of his Separation from Service to be a “specified employee” for purposes of Section 409A(a)(2)(B)(i) of the Code, to the extent delayed commencement of any portion of the benefits to which Executive is entitled under this
Agreement is required in order to avoid a prohibited distribution under Section 409A(a)(2)(B)(i) of the Code, such portion of Executive’s benefits shall not be provided to Executive prior to the earlier of (a) the expiration of the
six-month period measured from the date of Executive’s Separation from Service or (b) the date of Executive’s death. Upon the first business day following the expiration of the applicable Code Section 409A(a)(2)(B)(i) period, all
payments deferred pursuant to this Section 4 shall be paid in a lump sum to Executive, and any remaining payments due under the Agreement shall be paid as otherwise provided herein. For purposes of Section 409A of the Code (including,
without limitation, for purposes of Treasury Regulation Section 1.409A-2(b)(2)(iii)), Executive’s right to receive any installment payments payable hereunder shall be treated as a right to receive a series of separate payments and,
accordingly, each such installment payment shall at all times be considered a separate and distinct payment. 
  

 5 

 5. Excise Tax Limitation. 

(a) Notwithstanding anything contained in this Agreement to the contrary, in the event that the benefits provided by this Agreement,
together with all other payments and the value of any benefits received or to be received by Executive (“Payments”), constitute “parachute payments” within the meaning of Section 280G of the Code, and, but for this
Section 5, would be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then the Payments shall be made to Executive either (i) in full or (ii) as to such lesser amount as would
result in no portion of the Payments being subject to the Excise Tax, whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the Excise Tax, results in the receipt by Executive on an
after-tax basis, of the greatest amount of benefits, notwithstanding that all or some portion of the Payments may be subject to the Excise Tax. Unless Executive shall have given prior written notice specifying a different order to the Corporation to
effectuate any reduction contemplated by the preceding sentence, the Corporation shall reduce or eliminate the Payments by first reducing or eliminating cash payments and then by reducing those payments or benefits which are not payable in cash, in
each case in reverse order beginning with payments or benefits which are to be paid the farthest in time from the Determination (as hereinafter defined). Any notice given by Executive pursuant to the preceding sentence shall take precedence over the
provisions of any other plan, arrangement or agreement governing Executive’s rights and entitlements to any benefits or compensation. 

(b) Unless the Corporation and Executive otherwise agree in writing, an initial determination as to whether the Payments shall be reduced
and the amount of such reduction shall be made, at the Corporation’s expense, by the accounting firm that is the Corporation’s independent accounting firm as of the date of the Change in Control (the “Accounting Firm”).
The Accounting Firm shall provide its determination (the “Determination”), together with detailed supporting calculations and documentation, to the Corporation and Executive within twenty (20) days of the Date of Termination if
applicable, or such other time as requested by the Corporation or by Executive (provided Executive reasonably believes that Executive will receive Payments which may be subject to the Excise Tax), and if the Accounting Firm determines that there is
substantial authority (within the meaning of Section 6662 of the Code) that no Excise Tax is payable by Executive with respect to a Payment or Payments, it shall furnish Executive with an opinion reasonably acceptable to Executive that no
Excise Tax will be imposed with respect to any such Payment or Payments. Within ten (10) days of the delivery of the Determination to Executive, Executive shall have the right to dispute the Determination (the “Dispute”). If there is
no Dispute, the Determination shall be binding, final and conclusive upon the Corporation and Executive. 
 (c) As a result of
the uncertainty in the application of Sections 4999 and 280G of the Code, it is possible that the Payments to be made to, or provided for the benefit of, Executive either will be greater (an “Excess Payment”) or less (an
“Underpayment”) than the amounts provided for by the limitation contained in Section 5(a). 
 (i) If it
is established pursuant to a final determination of a court or an Internal Revenue Service (the “IRS”) proceeding which has been finally and conclusively resolved that an Excess Payment has been made, such Excess Payment shall be
deemed for all purposes to be a loan to Executive made on the date Executive received the Excess Payment and Executive shall repay the Excess Payment to the Corporation on demand (but not less than ten (10) days after written notice is received
by Executive) together with interest on the Excess Payment at the “Applicable Federal Rate” (as defined in Section 1274(d) of the Code) from the date of Executive’s receipt of such Excess Payment until the date of such repayment.

  

 6 

 (ii) In the event that it is determined by (A) the Accounting Firm, the Corporation
(which shall include the position taken by the Corporation, or together with its consolidated group, on its federal income tax return) or the IRS, (B) pursuant to a determination by a court, or (C) upon the resolution to Executive’s
satisfaction of the Dispute that an Underpayment has occurred, the Corporation shall pay an amount equal to the Underpayment to Executive within ten (10) days of such determination or resolution, together with interest on such amount at the
Applicable Federal Rate from the date such amount would have been paid to Executive until the date of payment. 
 6.
Successors; Binding Agreement. 
 (a) The Corporation shall require any successor (whether direct or indirect, by
purchase, merger, consolidation or otherwise) to all or substantially all of the business and/or assets of the Corporation to expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Corporation would
be required to perform it if no such succession had taken place. Unless expressly provided otherwise, “Corporation” as used herein shall mean the Corporation as defined in this Agreement and any successor to its business and/or assets as
aforesaid. 
 (b) This Agreement shall inure to the benefit of and be enforceable by Executive and Executive’s personal or
legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees. If Executive should die while any amount would still be payable to Executive hereunder had Executive continued to live, all such amounts,
unless otherwise provided herein, shall be paid in accordance with the terms of this Agreement to Executive’s devisee, legatee or other designee or, if there is no such designee, to Executive’s estate. 

7. Miscellaneous. 

(a) Modification or Amendment. No provision of this Agreement may be modified or amended unless such modification or amendment is
agreed to in writing and signed by Executive and an authorized officer of the Corporation as may be specifically designated by the Board or a committee thereof. 

(b) Waiver. No waiver by either party hereto at any time of any breach by the other party hereto of or compliance with, any
condition or provision of this Agreement to be performed by such other party shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time. 

(c) Non-Exclusivity of Rights. Notwithstanding Section 7(c), nothing in this Agreement shall prevent or limit
Executive’s continuing or future participation in any benefit, bonus, incentive or other plan or program provided by the Corporation (except for any severance or termination policies, plans, programs or practices) and for which Executive may
qualify, nor shall anything herein limit or reduce such rights as Executive may have under any other agreements with the Corporation (except for any severance, termination or other agreement regarding the subject matter of this Agreement). Amounts
which are vested benefits or which Executive is otherwise entitled to receive under any plan or program of the Corporation shall be payable in accordance with such plan or program, except as explicitly modified by this Agreement. 

 

 7 

 (d) Governing Law. The validity, interpretation, construction and performance of this
Agreement shall be governed by the laws of the State of California without regard to its conflicts of law principles. 
 (e)
Statutory References. All references to sections of the Exchange Act or the Code shall be deemed also to refer to any successor provisions to such sections. 

(f) Tax Withholding. Any payments provided for hereunder shall be paid net of any applicable withholding required under federal,
state or local law. 
 (g) Section Headings. The section headings contained in this Agreement are for convenience only,
and shall not affect the interpretation of this Agreement. 
 (h) Severability. The invalidity or unenforceability of any
provision of this Agreement shall not affect the validity or enforceability of any other provision of this Agreement, which shall remain in full force and effect. 

(i) Counterparts. This Agreement may be executed in several counterparts, each of which shall be deemed to be an original but all
of which together shall constitute one and the same instrument. 
 8. Arbitration. The parties hereby agree that any and
all claims or controversies regarding this Agreement shall be resolved, to the fullest extent permitted by law, by final, binding and confidential arbitration in Palo Alto, California conducted before a single arbitrator by Judicial Arbitration and
Mediation Services/Endispute (“JAMS”) or its successor, under the then applicable JAMS rules. By agreeing to this arbitration procedure, both parties waive the right to resolve any such dispute through a trial by jury or judge or by
administrative proceeding. The arbitrator shall: (a) have the authority to compel adequate discovery for the resolution of the dispute and to award such relief as would otherwise be permitted by law; and (b) issue a written arbitration
decision including the arbitrator’s essential findings and conclusions and a statement of the award. The Corporation shall pay all of JAMS’ arbitration fees. Nothing in this Agreement shall prevent either party from obtaining injunctive
relief in court if necessary to prevent irreparable harm pending the conclusion of any arbitration. 
 9. Fees and
Expenses. In connection with a Covered Termination which occurs within twelve (12) months after a Change in Control, the Corporation shall pay all reasonable legal fees and related expenses (including the costs of experts, evidence and
counsel) incurred by Executive as they become due as a result of (a) Executive seeking to obtain or enforce any right or benefit provided by this Agreement (including, but not limited to, any such fees and expenses incurred in connection with
the Dispute whether as a result of any applicable government taxing authority proceeding, audit or otherwise), and (b) Executive’s hearing before the Board as contemplated in Section I(b) of this Agreement. To the extent that any
reimbursements payable to Executive pursuant to this Section 9 are subject to the provisions of Section 409A of the Code, such reimbursements shall be paid to Executive no later than December 31 of the year following the year in which
the cost was incurred, the amount of expenses reimbursed in one year shall not affect the amount eligible for reimbursement in any subsequent year, and Executive’s right to reimbursement under this Section 9 will not be subject to
liquidation or exchange for another benefit. 
  

 8 

 10. Settlement of Claims. The Corporation’s obligation to make the payments
provided for in this Agreement and otherwise to perform its obligations hereunder shall not be affected by any circumstances, including, without limitation, any set-off, counterclaim, recoupment, defense or other right which the Corporation may have
against Executive or others. 
 11. At-Will Employment. Nothing contained in this Agreement shall (a) confer upon
Executive any right to continue in the employ of the Corporation, (b) constitute any contract or agreement of employment, or (c) interfere in any way with the at-will nature of Executive’s employment with the Corporation. 

IN WITNESS WHEREOF, the parties have executed this Agreement as of the Effective Date. 

 

	
	EXECUTIVE
	
	 /s/ DR. ROBERT MITTENDORFF

	Dr. Robert Mittendorff
	Title: VP, Marketing and Business Development
	
	 /s/ DR. FREDERIC MOLL

	By: Dr. Frederic Moll
	HANSEN MEDICAL, INC.

  

 9Consulting Agreement by and between the Registrant and Peter Osborne

 Exhibit 10.59 

CONSULTING AGREEMENT 

Effective February 24, 2010 (“Effective Date”), Peter Osborne, an individual with mailing address of 4960 Almaden Expy.,
#232, San Jose CA 95118 (“Consultant”) and Hansen Medical, Inc., a Delaware corporation having a principal place of business at 800 E. Middlefield Road, Mountain View, CA 94043 (“Company”) agree as follows: 

1. Services and Payment. Consultant agrees to undertake and complete the Services, and abide by the terms, set forth in Exhibit
A in accordance with and on the schedule specified in Exhibit A. As the only consideration due Consultant regarding the subject matter of this agreement (“Agreement”), Company will pay Consultant in accordance with Exhibit
A. 
 2. Ownership Rights; Proprietary Information; Publicity. 

a. Company shall own all right, title and interest (including patent rights, copyrights, trade secret rights, mask work rights, trademark
rights and all other intellectual and industrial property rights of any sort throughout the world) relating to any and all inventions (whether or not patentable), works of authorship, mask works, designations, designs, know-how, ideas and
information made or conceived or reduced to practice, in whole or in part, by Consultant during the term of this Agreement that relate to the subject matter of, or arise out of, the Services or any Proprietary Information (as defined below)
(collectively, “Inventions”) and Consultant will promptly disclose and provide all Inventions to Company. Consultant hereby makes all assignments necessary to accomplish the foregoing ownership. Consultant shall further assist Company, at
Company’s expense, to further evidence, record and perfect such assignments, and to perfect, obtain, maintain, enforce, and defend any rights assigned. Consultant hereby irrevocably designates and appoints Company as its agents and
attorneys-in-fact, coupled with an interest, to act for and on Consultant’s behalf to execute and file any document and to do all other lawfully permitted acts to further the foregoing with the same legal force and effect as if executed by
Consultant. 
 b. Consultant agrees that all Inventions and all other business, technical and financial information (including,
without limitation, the identity of and information relating to customers or employees) Consultant develops, learns or obtains in connection with Services or that are received by or for Company in confidence, constitute “Proprietary
Information.” Consultant will hold in confidence and not disclose or, except in performing the Services, use any Proprietary Information. However, Consultant shall not be obligated under this paragraph with respect to information Consultant can
document is or becomes readily publicly available without restriction through no fault of Consultant. Upon termination and as otherwise requested by Company, Consultant will promptly return to Company all items and copies containing or embodying
Proprietary Information, except that Consultant may keep its personal copies of its compensation records and this Agreement. Consultant also recognizes and agrees that Consultant has no expectation of privacy with respect to Company’s
telecommunications, networking or information processing systems (including, without limitation, stored computer files, email messages and voice messages) and that Consultant’s activity, and any files or messages, on or using any of those
systems may be monitored at any time without notice. 
  

 1 

 c. As additional protection for Proprietary Information, Consultant agrees that during the
period that it is to be providing Services (i) and for one year thereafter, Consultant will not encourage or solicit any employee or consultant of Company to leave Company for any reason and (ii) Consultant will not engage in any
activity that is competitive with the business, and Consultant will not assist any other person or organization in competing or in preparing to compete with any business of the Company. Without limiting the foregoing, Consultant may perform services
for other persons only if such services do not represent a conflict of interest or a breach of Consultant’s obligation under this Agreement or otherwise. 

d. To the extent allowed by law, Section 2.a and any license to Company hereunder includes all rights of paternity, integrity,
disclosure and withdrawal and any other rights that may be known as or referred to as “moral rights,” “artist’s rights,” “droit moral,” or the like. To the extent any of the foregoing is ineffective under
applicable law, Consultant hereby provides any and all ratifications and consents necessary to accomplish the purposes of the foregoing to the extent possible. Consultant will confirm any such ratifications and consents from time to time as
requested by Company. If any other person provides any Services, Consultant will obtain the foregoing ratifications, consents and authorizations from such person for Company’s exclusive benefit. 

e. If any part of the Services or Inventions is based on, incorporates, or is an improvement or derivative of, or cannot be reasonably
and fully made, used, reproduced, distributed and otherwise exploited without using or violating technology or intellectual property rights owned or licensed by Consultant and not assigned hereunder, Consultant hereby grants Company and its
successors a perpetual, irrevocable, worldwide royalty-free, non-exclusive, sublicensable right and license to exploit and exercise all such technology and intellectual property rights in support of Company’s exercise or exploitation of the
Services, Inventions, other work performed hereunder, or any assigned rights (including any modifications, improvements and derivatives of any of them). 

3. Warranty. Consultant warrants that: (i) the Services will be performed in a professional and workmanlike manner and that
none of such Services nor any part of this Agreement is or will be inconsistent with any obligation Consultant may have to others; (ii) all work under this Agreement shall be Consultant’s original work and none of the Services or
Inventions or any development, use, production, distribution or exploitation thereof will infringe, misappropriate or violate any intellectual property or other right of any person or entity (including, without limitation, Consultant); and,
(iii) Consultant has the full right to allow it to provide the Company with the assignments and rights provided for herein. 

4. Former or Conflicting Obligations. Consultant represents and warrants to the Company that Consultant will not disclose to the
Company, or use, or induce the Company to use, any proprietary information or trade secrets of others. Consultant represents that Consultant’s performance of services under this Agreement will not breach any agreement not to compete with others
or any agreement to keep in confidence proprietary information acquired by Consultant in confidence or in trust prior to the effective date of this Agreement. Consultant certifies that Consultant has no outstanding agreement or obligation that is in
conflict with any of the provisions of this Agreement, or that would preclude Consultant from complying with the provisions hereof. 
  

 2 

 5. Termination. 

a. Either party may terminate this Agreement with or without cause upon notice to the other party. Upon termination, the Company shall
pay Consultant all unpaid, undisputed amounts due for the Services completed prior to such termination within ten (10) business days of the date of termination. 

b. Sections 2 (subject to the limitations set forth in Section 2.c) through 9 of this Agreement and any remedies for breach of this
Agreement shall survive any termination or expiration. Company may communicate such obligations to any other (or potential) client or employer of Consultant. 

6. Independent Contractor; No Employee Benefits. Consultant under this Agreement is an independent contractor (not an employee or
other agent) solely responsible for the manner and hours in which Services are performed, is solely responsible for all taxes, withholdings, and other statutory, regulatory or contractual obligations of any sort (including, but not limited to, those
relating to workers’ compensation, disability insurance, Social Security, unemployment compensation coverage, the Fair Labor Standards Act, income taxes, etc.), and is not entitled to any to participate in any employee benefit plans, fringe
benefit programs, group insurance arrangements or similar programs. Consultant agrees to indemnify Company from any and all claims, damages, liability, settlement, attorneys’ fees and expenses, as incurred, on account of the foregoing or any
breach of this Agreement. 
 7. Assignment. This Agreement and the services contemplated hereunder are personal to
Consultant and Consultant shall not have the right or ability to assign, transfer, or subcontract any obligations under this Agreement without the written consent of Company. Any attempt to do so shall be void. Company may assign its rights and
obligations under this agreement in whole or part. 
 8. Notice. All notices under this Agreement shall be in writing,
and shall be deemed given when personally delivered, or three days after being sent by prepaid certified or registered U.S. mail to the address of the party to be noticed as set forth herein or such other address as such party last provided to the
other by written notice, or if sent by email, but only upon receipt of the email being acknowledged by the recipient. 
  

			
	If to Consultant:	  	The contact information appears below Consultant’s signature block.
		
	If to Company:	  	Hansen Medical, Inc.
		  	 800 E. Middlefield Road

Mountain View, CA 94043

		  	Attn: Chief Executive Officer
		  	Tel: (650) 404-5800

  

 3 

 9. Miscellaneous. Any breach of Section 2 or 3 will cause irreparable harm to
Company for which damages would not be an adequate remedy, and therefore, Company will be entitled to injunctive relief with respect thereto in addition to any other remedies. The failure of either party to enforce its rights under this Agreement at
any time for any period shall not be construed as a waiver of such rights. No changes or modifications or waivers to this Agreement will be effective unless in writing and signed by both parties. In the event that any provision of this Agreement
shall be determined to be illegal or unenforceable, that provision will be limited or eliminated to the minimum extent necessary so that this Agreement shall otherwise remain in full force and effect and enforceable. This Agreement shall be governed
by and construed in accordance with the laws of the State of California without regard to the conflicts of laws provisions thereof. In any action or proceeding to enforce rights under this Agreement, the prevailing party will be entitled to recover
costs and attorneys fees. Headings herein are for convenience of reference only and shall in no way affect interpretation of the Agreement. 
  

 4 

									
	PETER OSBORNE	 		 	HANSEN MEDICAL, INC.
					
	By	 	 /s/ PETER OSBORNE
	 	        	 	By	 	 /s/ FREDERIC H. MOLL, M.D.

		 		 		 		 	Frederic H. Moll, M.D.
		 		 		 		 	President & Chief Executive Officer

  

 5 

 EXHIBIT A 

 

	1.	Reporting to the Chief Executive Officer (the “CEO”) and other executives that the CEO may designate from time to time. 

 

	2.	Payment of $35,000 per month, payable bi-monthly in arrears, with partial months prorated based on the number of days of service. 

 

	3.	Subject to the approval of the Compensation Committee of the Company’s Board of Directors, Consultant will be granted a restricted stock unit award representing
the right to receive 10,000 shares of the Company’s Common Stock. The award will be subject to the terms and conditions applicable to restricted stock unit awards granted under the Company’s 2006 Equity Incentive Plan, as described in that
Plan and the applicable Restricted Stock Unit Agreement. 50% of the units subject to the restricted stock unit award will vest upon completion of three months of continuous service, and the remaining 50% of the units subject to the restricted stock
unit award will vest upon completion of six months of continuous service, as described in the applicable Restricted Stock Unit Agreement. In addition, if the Company terminates this Agreement prior to full vesting of the restricted stock unit award
for any reason other than Consultant’s material breach of this Agreement, Consultant will become vested in a number of units subject to the restricted stock unit agreement as though the award had been vesting on a monthly (rather than
quarterly) basis. 

  

	4.	Reasonable expenses, including Consultant’s time, for pre-approved travel will be reimbursed in accordance with the Company’s generally applicable policies.

  

	5.	“Services” means services as the Company’s Interim Chief Financial Officer which shall include service as the Company’s principal financial and
accounting officer and as the Company’s Chief Compliance Officer. 

  

 6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00173-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00173-of-00352.parquet"}]]